Evidence map›Paper›PMID 37814889›Full record

ArticleCirculation research2023

Body Mass Index, Adverse Pregnancy Outcomes, and Cardiovascular Disease Risk.

Sadiya S Khan, Lucia C Petito, Xiaoning Huang, Katharine Harrington, Rebecca B McNeil, Natalie A Bello, C Noel Bairey Merz, Eliza C Miller, Rupa Ravi, Christina Scifres and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Maternal Obesity Doubles the Risk of Preeclampsia and Eclampsia: Post-COVID Changes in a Brazilian Cohort of 2.3 Million Hospitalizations.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Pathophysiology of Maternal Obesity and Hypertension in Pregnancy.Journal of cardiovascular development and disease · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 13 institutions in 1 country.

Sadiya S KhanNorthwestern University Feinberg School of Medicine, Chicago, IL (S.S.K., L.C.P., X.H., K.H., P.C.Z., L.M.Y., P.G.).ORCID 0000-0003-0643-1859
Lucia C PetitoNorthwestern University Feinberg School of Medicine, Chicago, IL (S.S.K., L.C.P., X.H., K.H., P.C.Z., L.M.Y., P.G.).ORCID 0000-0002-0156-1219
Xiaoning HuangNorthwestern University Feinberg School of Medicine, Chicago, IL (S.S.K., L.C.P., X.H., K.H., P.C.Z., L.M.Y., P.G.).ORCID 0000-0001-5813-5993
Katharine HarringtonNorthwestern University Feinberg School of Medicine, Chicago, IL (S.S.K., L.C.P., X.H., K.H., P.C.Z., L.M.Y., P.G.).ORCID 0000-0002-2829-5133
Rebecca B McNeilResearch Triangle International, Research Triangle Park, NC (R.B.M.).ORCID 0000-0003-1351-1670
Natalie A BelloSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (N.A.B., C.N.B.M.).ORCID 0000-0003-3257-3623
C Noel Bairey MerzSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (N.A.B., C.N.B.M.).ORCID 0000-0002-9933-5155
Eliza C MillerColumbia University Irving Medical Center, New York City, NY (E.C.M., R.R.).ORCID 0000-0002-7108-8906
Rupa RaviColumbia University Irving Medical Center, New York City, NY (E.C.M., R.R.).ORCID 0000-0002-2821-5535
Christina ScifresIndiana University School of Medicine, Bloomington, IN (C.S.).
Janet M CatovUniversity of Pittsburgh School of Medicine, Pittsburgh, PA (J.M.C., M.R.).ORCID 0000-0002-9551-851X
Victoria L PembertonNational Heart, Lung, and Blood Institute, Bethesda, MD (V.L.P., J.V.).ORCID 0000-0001-5610-9070
Jasmina VaragicNational Heart, Lung, and Blood Institute, Bethesda, MD (V.L.P., J.V.).
Phyllis C ZeeNorthwestern University Feinberg School of Medicine, Chicago, IL (S.S.K., L.C.P., X.H., K.H., P.C.Z., L.M.Y., P.G.).
Lynn M YeeNorthwestern University Feinberg School of Medicine, Chicago, IL (S.S.K., L.C.P., X.H., K.H., P.C.Z., L.M.Y., P.G.).ORCID 0000-0002-6274-0544
Mitali RayUniversity of Pittsburgh School of Medicine, Pittsburgh, PA (J.M.C., M.R.).
Jin Kyung KimUniversity of California Irvine School of Medicine, Irvine, CA (J.K.K.).ORCID 0000-0002-0072-3845
Abbi D Lane-CordovaSchool of Public Health, University of South Carolina, Columbia, SC (A.D.L.-C.).ORCID 0000-0001-9620-1402
Jennifer LeweyUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, PA (J.L.).ORCID 0000-0003-3483-5527
Lauren H TheilenUniversity of Utah School of Medicine, Salt Lake City, UT (L.H.T.).ORCID 0000-0002-5662-6040
George R SaadeUniversity of Texas Medical Branch, Galveston, TX (G.R.S.).ORCID 0000-0001-7925-5302
Philip GreenlandNorthwestern University Feinberg School of Medicine, Chicago, IL (S.S.K., L.C.P., X.H., K.H., P.C.Z., L.M.Y., P.G.).ORCID 0000-0002-6327-2439
William A GrobmanThe Ohio State University College of Medicine, Columbus, OH (W.A.G.).
NICHD nuMoM2b and NHLBI nuMoM2b Heart Health Study Networks
Northwestern University · USCedars-Sinai Smidt Heart Institute · USColumbia University Irving Medical Center · USNational Heart Lung and Blood Institute · USUniversity of Pittsburgh · USIndiana University Bloomington · USRTI International · USThe Ohio State University · USThe University of Texas Medical Branch at Galveston · USUniversity of California, Irvine · USUniversity of Pennsylvania · USUniversity of South Carolina · USUniversity of Utah · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Stress and Racial Disparities in Preeclampsia - Clues from DNA Methylomic ProfilingU01HL145358 · NHLBI · RESEARCH TRIANGLE INSTITUTE · PI Rebecca Boehm McNeil · 2020 to 2026
$24.6M
Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Preterm Birth in Nulliparous Women: An Understudied Population at Great RiskU10HD063036 · NICHD · RESEARCH TRIANGLE INSTITUTE · PI PARKER, CORETTE BREEDEN · 2010 to 2015
$19.5M
Pregnancy as a Window to Future Cardiovascular Health: Adverse Pregnancy Outcomes Supplement RequestU10HL119991 · NHLBI · RESEARCH TRIANGLE INSTITUTE · PI PARKER, CORETTE BREEDEN · 2013 to 2018
$12.6M
Institute for Clinical and Translational ScienceUL1TR000153 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M · 2012 to 2015
$12.1M
Vascular Contributions to Cognitive Impairment after Adverse Pregnancy Outcomes: the nuMoM2b-Heart Health StudyR01NS122815 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Eliza C Miller · 2021 to 2026
$3.7M
PRegnancy OuTcomEs and subclinical Cardiovascular disease sTudy: (PROTECT)R01HL161514 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Sadiya Sana Khan · 2022 to 2026
$3.3M
Prevention of Preterm Birth in high Risk Nulliparous PatientsU10HD063047 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WAPNER, RONALD · 2010 to 2014
$1.9M
Preterm Birth in Nulliparous Women: An Understudied Population at Great RiskU10HD063053 · NICHD · UNIVERSITY OF UTAH · PI SILVER, ROBERT M. · 2010 to 2014
$1.7M
NCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1 TR000153NCATS NIH HHS UL1 TR000439NCATS NIH HHS UL1 TR001108NCATS NIH HHS UL1 TR001881NHLBI NIH HHS K23 HL153667NHLBI NIH HHS K23 HL159316NHLBI NIH HHS R01 HL161514NHLBI NIH HHS U01 HL145358NHLBI NIH HHS U10 HL119989NHLBI NIH HHS U10 HL119990NHLBI NIH HHS U10 HL119991NHLBI NIH HHS U10 HL119992NHLBI NIH HHS U10 HL119993NHLBI NIH HHS U10 HL120006NHLBI NIH HHS U10 HL120018NHLBI NIH HHS U10 HL120019NHLBI NIH HHS U10 HL120034NICHD NIH HHS U10 HD063020NICHD NIH HHS U10 HD063036NICHD NIH HHS U10 HD063037NICHD NIH HHS U10 HD063041NICHD NIH HHS U10 HD063046NICHD NIH HHS U10 HD063047NICHD NIH HHS U10 HD063048NICHD NIH HHS U10 HD063053NICHD NIH HHS U10 HD063072NINDS NIH HHS K23 NS107645NINDS NIH HHS R01 NS122815
6 · The paper itself

Abstract

backgroundObesity is a well-established risk factor for both adverse pregnancy outcomes (APOs) and cardiovascular disease (CVD). However, it is not known whether APOs are mediators or markers of the obesity-CVD relationship. This study examined the association between body mass index, APOs, and postpartum CVD risk factors.

methodsThe sample included adults from the nuMoM2b (Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-To-Be) Heart Health Study who were enrolled in their first trimester (6 weeks-13 weeks 6 days gestation) from 8 United States sites. Participants had a follow-up visit at 3.7 years postpartum. APOs, which included hypertensive disorders of pregnancy, preterm birth, small-for-gestational-age birth, and gestational diabetes, were centrally adjudicated. Mediation analyses estimated the association between early pregnancy body mass index and postpartum CVD risk factors (hypertension, hyperlipidemia, and diabetes) and the proportion mediated by each APO adjusted for demographics and baseline health behaviors, psychosocial stressors, and CVD risk factor levels.

resultsAmong 4216 participants enrolled, mean±SD maternal age was 27±6 years. Early pregnancy prevalence of overweight was 25%, and obesity was 22%. Hypertensive disorders of pregnancy occurred in 15%, preterm birth in 8%, small-for-gestational-age birth in 11%, and gestational diabetes in 4%. Early pregnancy obesity, compared with normal body mass index, was associated with significantly higher incidence of postpartum hypertension (adjusted odds ratio, 1.14 [95% CI, 1.10-1.18]), hyperlipidemia (1.11 [95% CI, 1.08-1.14]), and diabetes (1.03 [95% CI, 1.01-1.04]) even after adjustment for baseline CVD risk factor levels. APOs were associated with higher incidence of postpartum hypertension (1.97 [95% CI, 1.61-2.40]) and hyperlipidemia (1.31 [95% CI, 1.03-1.67]). Hypertensive disorders of pregnancy mediated a small proportion of the association between obesity and incident hypertension (13% [11%-15%]) and did not mediate associations with incident hyperlipidemia or diabetes. There was no significant mediation by preterm birth or small-for-gestational-age birth.

conclusionsThere was heterogeneity across APO subtypes in their association with postpartum CVD risk factors and mediation of the association between early pregnancy obesity and postpartum CVD risk factors. However, only a small or nonsignificant proportion of the association between obesity and CVD risk factors was mediated by any of the APOs, suggesting APOs are a marker of prepregnancy CVD risk and not a predominant cause of postpartum CVD risk.

Indexed as

Cardiovascular DiseasesDiabetes, GestationalHyperlipidemiasHypertension, Pregnancy-InducedPremature BirthAdultBody Mass IndexFemaleHumansInfant, NewbornObesityPregnancyPregnancy OutcomeRisk FactorsUnited StatesYoung Adultbody mass indexcardiovascular diseaseshypertensionobesitypregnancy

Identifiers

PMID37814889
PMCPMC10578703
OpenAlexW4387472892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.